This site is intended for Healthcare Professionals only
2023-02-27 14:00:10 (3 year(s) ago)
IPS Pharma is recalling specific batches of levothyroxine oral suspension from pharmacies and impacted patients due to the concentration of levothyroxine being greater than the amount stated on the label.